VHI Stock Recent News

Final Short Form Prospectus Accessible on SEDAR+ Toronto, Ontario--(Newsfile Corp. - January 3, 2025) - Vitalhub Corp. (TSX: VHI) (the "Company" or "VitalHub") is pleased to announce that, in connection with its previously announced "bought deal" public financing, it has filed a final short form prospectus dated January 2, 2025 (the "Final Prospectus") to qualify the distribution of 2,752,300 common shares from the treasury of the Company (the "Common Shares") at a price of $10.90 per Common Share (the "Offering Price") and up to an additional 412,845 Common Shares at the Offering Price to be issued upon exercise of an over-allotment option, the particulars of which are further described in the Final Prospectus (the "Offering"). Closing is expected on or about January 9, 2025, and is subject to regulatory approval, including that of the Toronto Stock Exchange.

TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has amended and expanded its existing credit facilities with The Bank of Nova Scotia to further strengthen the Company's financial flexibility. Under the terms of the amendment, the Company's total committed borrowing capacity has increased to $65 million from $33 million.

TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has successfully completed an implementation of its regional patient flow and whole-system visibility platform, SHREWD, to support improved patient flow and safer, more effective care coordination.

Dallas, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on December 19, 2024 to stockholders of record at the close of business on November 29, 2024.

Dallas, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $57.5 million, or $2.01 per share, in the third quarter of 2024 compared to a net loss of $5.8 million, or $.21 per share, in the third quarter of 2023. For the first nine months of 2024, Valhi reported net income attributable to Valhi stockholders of $85.2 million, or $2.99 per share, compared to a net loss of $14.8 million, or $.52 per share, in the first nine months of 2023. Net income attributable to Valhi stockholders increased in the third quarter and first nine months of 2024 as compared to the same periods in 2023 primarily due to higher operating results from the Chemicals Segment and a non-cash gain discussed below.

TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it will release its financial results for its third quarter 2024 ended September 30th, 2024, after market close on November 13th, 2024. The Company will subsequently hold a conference call via Zoom on November 14th, 2024, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow.

TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Strata Health Solutions Inc. (“Strata Health”), a leading provider of patient flow solutions internationally.

TORONTO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is proud to announce its inclusion in the 2024 TSX30™, the Toronto Stock Exchange's prestigious ranking of the top 30 performing stocks over the past three years. VitalHub has achieved the 26th position on this esteemed list, showcasing a remarkable 136% three-year dividend-adjusted share price performance and a 231% increase in market capitalization.

Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is proud to announce its inclusion in the 2024 TSX30™, the Toronto Stock Exchange's prestigious ranking of the top 30 performing stocks over the past three years. VitalHub has achieved the 26th position on this esteemed list, showcasing a remarkable 136% three-year dividend-adjusted share price performance and a 231% increase in market capitalization.

Inflation remains on fire, CPI reached 9.1% and the Fed continues to hike rates to curb inflation. Negative sentiment has investors hyper-sensitive to declines in their portfolios. With fear moving the markets, investors should consider stocks that can weather all storms.